Effective Use of Autoantibody Tests in the Diagnosis of Systemic Autoimmune Disease

Annals of the New York Academy of Sciences - Tập 1050 Số 1 - Trang 217-228 - 2005
Robert H. Lyons1, Sonali Narain, Cody Nichols, Minoru Satoh, Westley H. Reeves
1Division of Rheumatology and Clinical Immunology, University of Florida, P.O. Box 100221, Gainesville, FL, 32610-0221, USA

Tóm tắt

Abstract: Screening for disease‐specific autoantibodies may be useful in asymptomatic ANA‐positive individuals as a means of evaluating the risk of developing a systemic autoimmune disease such as systemic lupus erythematosus (SLE), polymyositis/dermatomyositis /PM/DM), scleroderma (SSc), Sjögren's syndrome (SS), rheumatoid arthritis (RA), or primary biliary cirrhosis (PBC) in the future. In patients with known or suspected systemic autoimmune disease, a panel of disease‐specific markers may help to establish a diagnosis and to assess the prognosis. The great strides in autoantibody testing over the last 20 years make it feasible to use specific autoantibody markers to improve diagnostic accuracy in systemic autoimmune disease. New technology enabling screening for multiple autoantibodies may further enhance the clinical usefulness of autoantibody testing, making it possible to diagnose autoimmune disease in its earliest stages and to intervene before serious end organ damage occurs.

Từ khóa


Tài liệu tham khảo

Reeves W.H. S. Narain & M. Satoh. 2004. Autoantibodies in systemic lupus erythematosus.InArthritis and Allied Conditions pp. 1497–1521. Lippincott/Williams & Wilkins. Philadelphia.

Shiel W.C., 1989, The diagnostic associations of patients with antinuclear antibodies referred to a community rheumatologist, J. Rheumatol, 16, 782

10.1016/S0140-6736(96)04410-8

10.1016/0016-5085(90)90968-7

Vlachoyiannopoulos P.G., 1998, Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic, J. Rheumatol, 25, 886

10.1177/096120339500400113

10.1056/NEJMoa021933

10.1046/j.1365-3083.2001.00959.x

10.1002/art.1780340111

10.1097/00124743-199604000-00006

10.1002/art.1780311004

Aho K., 1991, Rheumatoid factors antedating clinical rheumatoid arthritis J, Rheumatol, 18, 1282

10.1002/art.11223

10.1002/art.20044

10.1006/jaut.1996.0051

10.1016/0140-6736(90)90013-U

10.1172/JCI117247

10.1016/S0140-6736(01)05415-0

10.1111/j.1365-2265.1995.tb01894.x

10.1016/S0140-6736(80)92276-X

10.1001/archinte.164.22.2435

Hooper B., 1972, Autoimmunity in a rural community, Clin. Exp. Immunol, 12, 79

Hawkins B.R., 1979, Autoantibodies in an Australian population, I. Prevalence and persistence. J. Clin. Lab. Immunol, 2, 211

10.1002/art.1780400909

Rosenberg A.M., 1999, Prevalence of antinuclear antibodies in a rural population, J. Toxicol. Environ. Health, 57, 225, 10.1080/009841099157674

10.1084/jem.165.3.750

10.7326/0003-4819-108-6-829

10.1002/1529-0131(199907)42:7<1347::AID-ANR7>3.0.CO;2-#

10.1172/JCI114696

Rothfield N.F., 1992, Autoantibodies in scleroderma, Rheum. Dis. Clin. North Am, 18, 483, 10.1016/S0889-857X(21)00738-9

Rodriguez‐Sanchez J., 1987, A new autoantibody in scleroderma that recognizes a 90‐kDa component of the nucleolus organizing region of chromatin, J. Immunol, 139, 2579, 10.4049/jimmunol.139.8.2579

10.1002/art.1780390808

Schnitz W., 1996, Anti/PM/Scl autoantibodies in patients without clinical poymyositis or scleroderma, J. Rheumatol, 23, 1729

Targoff I.N., 1992, Autoantibodies in polymyositis, Rheum. Dis. Clin. North Am, 18, 455, 10.1016/S0889-857X(21)00737-7

10.1002/art.1780251101

10.1002/art.1780400910

Edworthy S.M., 1988, Analysis of the 1982 ARA lupus criteria data set by recursive partitioning methodology: new insights into the relative merit of individual criteria, J. Rheumatol, 15, 1493

Slater C.A., 1996, Antinuclear antibody testing, Arch. Intern. Med, 156, 1421, 10.1001/archinte.1996.00440120079007

10.1016/S0140-6736(95)90114-0

10.1056/NEJM198707303170503

10.1002/art.1780370303

10.1172/JCI110523

Rozman B., 2000, Immunoserological aspects of idiopathic inflammatory muscle disease, Wien. Klin. Wochenschr, 112, 722

10.1067/mjd.2002.121037

10.1177/096120339300200503

10.7326/0003-4819-111-2-143

10.1002/art.1780310207

10.1002/art.1780310309

10.4049/jimmunol.153.12.5838

10.1002/1529-0131(200005)43:5<1074::AID-ANR18>3.0.CO;2-E

10.1002/art.1780370619

10.1002/art.1780331210

10.1172/JCI114461

Bernstein R.M., 1984, Cellular protein and RNA antigens in autoimmune disease, Mol. Biol. Med, 2, 105

Thông tin
Thông tin xuất bản

Annals of the New York Academy of Sciences

Tập 1050 Số 1

217-228

Thông tin tác giả